BU-224 produces spinal antinociception as an agonist at imidazoline I-2 receptors

被引:44
作者
Diaz, A [1 ]
Mayet, S [1 ]
Dickenson, AH [1 ]
机构
[1] UCL, DEPT PHARMACOL, LONDON WC1E 6BT, ENGLAND
基金
英国惠康基金;
关键词
imidazoline receptor; BU-224 (2-(4,5-dihydroimidazol-2yl)-quinoline hydrochloride)); nociception; spinal cord; (rat);
D O I
10.1016/S0014-2999(97)01118-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this electrophysiological study, the effect of BU-224 (2-(4,5-dihydroimidazol-2yl)-quinoline hydrochloride)), a novel high affinity imidazoline 1(2) receptor ligand, was tested on the responses of nociceptive neurones in the spinal dorsal horn. When applied spinally, akin to an intrathecal application (i.t.), BU-224 (5-250 mu g) reduced the nociceptive responses of dorsal horn neurones, producing a dose-dependent inhibition of C-fibre evoked responses, postdischarge and wind-up of the cells. A complete block of the antinociceptive effects was produced when idazoxan (100 mu g), with both alpha(2)-adrenoceptor and imidazoline I-2 receptor antagonist actions, was administered i.t. 10 min prior to the maximal dose of BU-224 tested. The nonselective alpha(2)-adrenoceptor antagonist, yohimbine (150 mu g) only partially attenuated the inhibitory effects of BU-224 when administered i.t. 10 min prior. The highly selective alpha(2)-adrenoceptor antagonist, atipamezole (100 mu g) produced no greater reversal than yohimbine under the same conditions. Although BU-224 has been reported to possess high affinity for imidazoline I-2 receptors, a minor action at spinal alpha(2)-adrenoceptor receptors cannot be discounted. These results demonstrate that BU-224 is an agonist and that imidazoline I-2 receptors, present in the dorsal horn, might play a role in spinal nociception, although further studies are needed to fully elucidate their functional roles. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:9 / 15
页数:7
相关论文
共 30 条
[1]  
BRADLEY KJ, 1996, J PHYSL, V495, pP46
[2]   RS-45041-190 - A SELECTIVE, HIGH-AFFINITY LIGAND FOR I-2 IMIDAZOLINE RECEPTORS [J].
BROWN, CM ;
MACKINNON, AC ;
REDFERN, WS ;
WILLIAMS, A ;
LINTON, C ;
STEWART, M ;
CLAGUE, RU ;
CLARK, R ;
SPEDDING, M .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 (02) :1737-1744
[3]  
CARPENE C, 1995, J PHARMACOL EXP THER, V272, P681
[4]   IMIDAZOLINE BINDING-SITES IN HUMAN PLACENTA - EVIDENCE FOR HETEROGENEITY AND A SEARCH FOR PHYSIOLOGICAL-FUNCTION [J].
DIAMANT, S ;
ELDARGEVA, T ;
ATLAS, D .
BRITISH JOURNAL OF PHARMACOLOGY, 1992, 106 (01) :101-108
[5]   SUPRASPINAL MORPHINE AND DESCENDING INHIBITIONS ACTING ON THE DORSAL HORN OF THE RAT [J].
DICKENSON, AH ;
LEBARS, D .
JOURNAL OF PHYSIOLOGY-LONDON, 1987, 384 :81-+
[6]   ELECTROPHYSIOLOGICAL STUDIES ON THE EFFECTS OF INTRATHECAL MORPHINE ON NOCICEPTIVE NEURONS IN THE RAT DORSAL HORN [J].
DICKENSON, AH ;
SULLIVAN, AF .
PAIN, 1986, 24 (02) :211-222
[7]   CLONIDINE BINDS TO IMIDAZOLE BINDING-SITES AS WELL AS ALPHA-2-ADRENOCEPTORS IN THE VENTROLATERAL MEDULLA [J].
ERNSBERGER, P ;
MEELEY, MP ;
MANN, JJ ;
REIS, DJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 134 (01) :1-13
[8]   EVIDENCE FOR SPINAL N-METHYL-D-ASPARTATE RECEPTOR INVOLVEMENT IN PROLONGED CHEMICAL NOCICEPTION IN THE RAT [J].
HALEY, JE ;
SULLIVAN, AF ;
DICKENSON, AH .
BRAIN RESEARCH, 1990, 518 (1-2) :218-226
[9]  
Hieble J P, 1995, Ann N Y Acad Sci, V763, P8, DOI 10.1111/j.1749-6632.1995.tb32387.x
[10]   An I-2 imidazoline ligand, RS 45041, potentiates hyperalgesia in acute arthritis [J].
Houghton, AK ;
Westlund, KN .
NEUROREPORT, 1996, 7 (09) :1497-1501